FOLLOW-UP CT - ON KEYTRUDA ALONE

​I began my 7th cycle of enfortumab vedotin and pembrolizumab (Padcev+Keytruda) on May 31.  I continued with pembrolizumab only on June 21.  On September 13 I began my 6th cycle of pembrolizumab only.  This is my second follow-up using CT with contrast since changing to immunotherapy alone.  I would like to schedule a PET/CT and/or circulating tumor DNA to confirm - but I am happy to see a report of no evidence of recurrence or new disease by CT.